嗜铬细胞瘤与原发性高血压左心室肥厚检出率的差异

Comparison of incidence of left ventricular hypertrophy between pheochromocytoma and essential hypertension

  • 摘要: 目的探讨嗜铬细胞瘤(PHEO)与原发性高血压相比左心室肥厚(LVH)发生比例是否有差异,并分析潜在的影响因素。方法通过电子病历系统收集西安交通大学第一附属医院及成都医学院第一附属医院2009年1月至2017年12月经过手术病理确诊的PHEO患者150例,排除PHEO资料不全者37例,最终纳入PHEO患者113例。基于24 h全天平均收缩压、年龄及性别匹配的原发性高血压患者113例(选自病例数据库中2009年1月至2017年12月第一诊断为原发性高血压的患者)为对照组。对他们的基本资料、临床特点、实验室检查及超声心动图资料进行对比分析。根据有无LVH进行log-binomial回归分析,探讨影响LVH的潜在因素。结果最终113例PHEO患者与113例原发性高血压患者匹配成功并纳入分析。在PHEO患者中,血浆总胆固醇水平(4.5±1.1)比(4.2±0.8)mmol/L,合并糖尿病比例(20%比2%),心率(84.0±26.7)比(68.3±13.2)次/min,24 h尿儿茶酚胺升高比例(42.3%比24.8%)、24 h尿香草扁桃酸(VMA)升高比例(54.9%比5.3%)、24 h尿肾上腺素升高比例(31.8%比8.0%)高于对照组患者(均P<0.05)。PHEO组体质量指数(BMI)(21.5±2.9)比(24.0±3.2)kg/m2,心血管病家族史(4.4%比58.4%),病程12(1~54)比60(4~96)月低于对照组患者(均P<0.05)。两组相比,PHEO组的LVH检出率更高21.4%比10.9%;相对危险度(RR)=2.20(1.05~4.72)。以LVH为因变量,以PHEO、性别、年龄、病程、BMI、心率、糖尿病、总胆固醇、24 h尿儿茶酚胺升高、24 h尿VMA升高、24 h尿肾上腺素升高为自变量的log-binomial回归分析显示,糖尿病(RR=2.08)及24 h尿儿茶酚胺升高(RR=2.81)是LVH的促进因素(P<0.05)。结论 PHEO患者的LVH检出率是原发性高血压患者的2.2倍,可能的机制包括糖尿病和儿茶酚胺长期的毒性作用。

     

    Abstract: Objective To explore whether patients with pheochromocytoma(PHEO) have an excess rate of left ventricular hypertrophy(LVH) as compared to essential hypertensive patients and investigate the influencing factors. Methods The medical records of 150 consecutive PHEO patients treated in the First Affiliated Hospital of Xi’an Jiaotong University and the First Affiliated Hospital of Chengdu Medical College from January 2009 to December 2017 were reviewed. All subjects underwent tumors removal and the final diagnosis was confirmed by histopathology. A total of 37 cases were excluded due to incomplete data. Finally, a total of 113 patients with PHEO were deemed eligible and analysed in our analysis. A total of 113 patients with matching 24 h systolic blood pressure, age and gender were selected whose primary diagnose was essential hypertension from the case database from January 2009 to December 2017, and served as a reference group. The basic characteristics, clinical features, laboratory examination and echocardiographic data were compared and analysed. Based on the log-binomial regression analysis, the influencing factors of LVH were explored. Results The analysis was performed on 113 PHEO patients and 113 essential hypertensive control subjects. PHEO patients had higher plasma cholesterol levels (4.5±1.1) vs(4.2±0.8)mmol/L, higher prevalence of diabetic(20% vs 2%), faster heart rates (84.0±26.7) vs(68.3±13.2)beats/min, higher proportion of elevated 24 h urinary catecholamines(42.3% vs 24.8%), elevated 24 h urinary vanillyl mandelie acid(VMA)(54.9% vs 5.3%) and elevated 24 h urinary epinephrine(E)(31.8% vs 8.0%), lower mean body mass index(BMI) (21.5±2.9) vs(24.0±3.2)kg/m~2, lower proportion of family history(4.4% vs 58.4%, P<0.001) and shorter course 12(1-54) vs 60(4-96)months as compared to the reference group(P<0.05). The prevalence of LVH was significantly higher in patients with PHEO 21.4% vs 10.9%; relative risk(RR)=2.20(1.05-4.72) as compared to reference group. Serving LVH as the dependent variable, the following variables were included in the multivariate analysis: PHEO, age, gender, course of disease, BMI, diabetes, heart rate, total cholesterol, elevated 24 h urinary catecholamines, elevated 24 h urinary VMA, and elevated 24 h urinary E. The results showed that mellitus and elevated 24 h urinary catecholamines were important variables accelerating LVH, with significant regression coefficient(RR=2.08 and 2.81, respectively, P<0.05). Conclusions The PHEO group comprised a higher rate(RR=2.21) of LVH when compared to essential hypertension patients. The most likely explanation for the excess rate might involve mellitus and catecholamines overproduction.

     

/

返回文章
返回